Vincent’s primary area of investigation involves the development of immune-based cancer therapies. Specifically, he is exploring combinatorial approaches that employ targeted inhibitors and immunomodulatory drugs. Additionally, he is working on establishing cancer vaccines that leverage preexisting pools of tumor cross-reactive immune cells which are normally involved in recognizing gut microbiota.